Clinical Endocannabinoid Deficiency was a theory posited by Dr. Russo back in 2001 in which he theorized that low endocannabinoid levels could be behind a range of chronic conditions such as IBS, fibromyalgia, migraines, and other treatment-resistant syndromes. Dr. Russo suggested that because these conditions are all developed over time, rather than congenitally, and that they could be a result of disturbances to the ECS. This also means there’s a possibility of reversing them.
To help make your holidaze more "dazey," I've crafted five festive recipes that combine seasonal…
As of December 2024, it has become official: the current Congress will not provide any…
In a significant development for the burgeoning cannabis industry, the U.S. Census Bureau has reported…
We looked into our crystal bong and this is what we saw. The post Cannabis…
The ongoing debate over cannabis legalization in Florida reflects broader national trends regarding marijuana policy.…
Shop the winners near you. The post 2024’s cannabis award-winners and where to buy them…